Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse. Scope of the Report: This report focuses on the Narcolepsy Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Jazz Pharmaceuticals Teva Pharmaceutical Novartis Mylan Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Antioxidants Type Stimulants Type Other Market Segment by Applications, can be divided into Daytime Extreme Sleepiness Cataplexia Others There are 15 Chapters to deeply display the North America Narcolepsy Drug market. Chapter 1, to describe Narcolepsy Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Narcolepsy Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Narcolepsy Drug, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Narcolepsy Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Narcolepsy Drug Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Narcolepsy Drug Introduction 1.2 Market Analysis by Type 1.2.1 Antioxidants Type 1.2.2 Stimulants Type 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 Daytime Extreme Sleepiness 1.3.2 Cataplexia 1.3.3 Others 1.4 Market Analysis by Countries 1.4.1 United States Status an
